Hepatobiliary and Pancreatic: Nivolumab-related cholangiopathy.

Hamoir, C

Hepatobiliary and Pancreatic: Nivolumab-related cholangiopathy. [electronic resource] - Journal of gastroenterology and hepatology Oct 2018 - 1695 p. digital

Publication Type: Case Reports; Journal Article

1440-1746

10.1111/jgh.14136 doi


Aged
Antineoplastic Agents, Immunological--adverse effects
Bile Ducts, Intrahepatic--diagnostic imaging
Carcinoma, Non-Small-Cell Lung--therapy
Cholangiopancreatography, Magnetic Resonance
Cholangitis--chemically induced
Humans
Immunotherapy--adverse effects
Lung Neoplasms--therapy
Male
Nivolumab--adverse effects